Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 22, 1987 - Issue sup134
Submit an article Journal homepage
84
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Famotidine: A Notable Lack of Drug Interactions

T. J. Humphries Thomas Jefferson University, Philadelphia, and Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania, USA
Pages 55-60 | Published online: 08 Jul 2009

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vijay V Upreti, Yan Song, Jessie Wang, Wonkyung Byon, Rebecca A Boyd, Janice M Pursley, Frank LaCreta & Charles E Frost. (2013) Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. Clinical Pharmacology: Advances and Applications 5, pages 59-66.
Read now

Articles from other publishers (49)

Shunsuke Nakamura, Shingo Masuda, Shinya Oda, Daisuke Yamakawa, Shota Yamaguchi, Tamaki Ishima, Natsuka Kimura & Kenichi Aizawa. (2024) Polypharmacy-Related Shock Symptoms and Complications Associated with Phenothiazine: A Case Report. Internal Medicine.
Crossref
Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, Farid Raeisi, Kimia Masoumi, Sina Khodakarami & Omid Raiesi. (2022) Therapeutic Status of Famotidine in COVID-19 Patients: A Review. Infectious Disorders - Drug Targets 22:3.
Crossref
Siri Kalyan Chirumamilla, Venkatesh Teja Banala, Masoud Jamei & David B. Turner. (2021) Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents. Pharmaceutics 13:8, pages 1169.
Crossref
Yu Jiang, Ziping Liu, Jörg Holenz & Hua Yang. 2016. Lead Generation. Lead Generation 183 220 .
John Chung, Fernando Alvarez-Nunez, Vincent Chow, Dominick Daurio, John Davis, Michael Dodds, Maurice Emery, Kevin Litwiler, Anne Paccaly, Joanna Peng, Brooke Rock, Larry Wienkers, Charles Yang, Zhigang Yu & Jan Wahlstrom. (2015) Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility. Journal of Pharmaceutical Sciences 104:4, pages 1522-1532.
Crossref
Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva & F. Peter Guengerich. (2014) Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes. Drug Metabolism and Disposition 42:9, pages 1438-1446.
Crossref
Toru Arai, Yoshikazu Inoue, Yumiko Sasaki, Kazunobu Tachibana, Keiko Nakao, Chikatoshi Sugimoto, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi & Seiji Hayashi. (2014) Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Respiratory Investigation 52:2, pages 136-143.
Crossref
Jodie Pang, Gena Dalziel, Brian Dean, Joseph A. Ware & Laurent Salphati. (2013) Pharmacokinetics and Absorption of the Anticancer Agents Dasatinib and GDC-0941 under Various Gastric Conditions in Dogs – Reversing the Effect of Elevated Gastric pH with Betaine HCl. Molecular Pharmaceutics 10:11, pages 4024-4031.
Crossref
Ophelia Q. P. Yin, Véronique Bédoucha, Tracey McCulloch, Cheng Zheng, Wei Zhou, Azra Hussaini & Steven Novick. (2012) Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers. Cancer Chemotherapy and Pharmacology 71:1, pages 219-226.
Crossref
Alfonso E. Bello. (2012) DUEXIS ® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug . Therapeutic Advances in Musculoskeletal Disease 4:5, pages 327-339.
Crossref
Loren Laine, Alan J Kivitz, Alfonso E Bello, Amy Y Grahn, Michael H Schiff & Ali S Taha. (2012) Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers. American Journal of Gastroenterology 107:3, pages 379-386.
Crossref
Prabowo Tunggal, Fook-Hong Ng, Kwok-Fai Lam, Francis K.L. Chan & Yuk-Kong Lau. (2011) Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial. American Heart Journal 162:5, pages 870-874.
Crossref
R. Marcus Fancher, Hongjian Zhang, Bogdan Sleczka, George Derbin, Richard Rockar & Punit Marathe. (2011) Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test Compounds. Journal of Pharmaceutical Sciences 100:7, pages 2979-2988.
Crossref
Paraskevas Tzanavaras. (2011) Development and validation of an ultra-fast liquid chromatographic method for the quality control of famotidine formulations using a short monolithic stationary phase. Open Chemistry 9:3, pages 446-452.
Crossref
Matthew Price & Amy Schueler. (2010) Understanding Clopidogrel's Interaction with CYP2C19 Inhibitors. The Journal for Nurse Practitioners 6:9, pages 715-720.
Crossref
Hye-Kyong JeongChang-Hwan ParkChung-Hwan JunGi-Hoon LeeHyung-Il KimHyun-Soo KimSung-Kyu ChoiJong-Sun Rew. (2007) A Prospective Randomized Trial of Either Famotidine or Pantoprazole for the Prevention of Bleeding after Endoscopic Submucosal Dissection. Journal of Korean Medical Science 22:6, pages 1055.
Crossref
Tanja Wegat, Katrin Metzman, Kristina Leuner & Walter E. Müller. (2006) Antazida und H 2 ‐Antihistaminika bei Hyperazidität: Wissenswertes zu Nebenwirkungen und Interaktionen . Pharmazie in unserer Zeit 36:1, pages 44-51.
Crossref
Kamal M. Matar. (2005) Influence of famotidine on verapamil pharmacokinetics in rats. European Journal of Drug Metabolism and Pharmacokinetics 30:3, pages 219-222.
Crossref
T. FURUTA, N. SHIRAI, M. SUGIMOTO, A. NAKAMURA, K. OKUDAIRA, M. KAJIMURA & A. HISHIDA. (2005) Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. Alimentary Pharmacology and Therapeutics 22:1, pages 67-74.
Crossref
Hideyuki Motohashi, Yuichi Uwai, Kiyo Hiramoto, Masahiro Okuda & Ken-ichi Inui. (2004) Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). European Journal of Pharmacology 503:1-3, pages 25-30.
Crossref
Wilson Roberto Malfará, Carolina Paula Pereira, Antonio Cardozo Dos Santos & Regina Helena Costa Queiroz. (2002) Effects of H2-receptor antagonists on dapsone-induced methaemoglobinaemia in rats. Pharmacological Research 45:4, pages 269-273.
Crossref
Yoko Iida, Shinichi Nishi & Akira Asada. (2001) Effect of Mild Therapeutic Hypothermia on Phenytoin Pharmacokinetics. Therapeutic Drug Monitoring 23:3, pages 192-197.
Crossref
Humphries & Merritt. (1999) Review article: drug interactions with agents used to treat acid-related diseases. Alimentary Pharmacology & Therapeutics 13, pages 18-26.
Crossref
P Barrau, C Giannelloni, G Gindre, JP Bérard & JE Bazin. (1998) Effet prolongé du midazolam avec retard de réveil postanesthésique par interférence possible avec la famotidine. Annales Françaises d'Anesthésie et de Réanimation 17:5, pages 361-364.
Crossref
Takashi Aono. (1995) The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: A comparison between omeprazole and famotidine. Surgery Today 25:9, pages 816-821.
Crossref
Bertil KJ Wagner, David W Amory, Claudine M Majcher, Louis T DiFazio, Gregory E Scott & Alan J Spotnitz. (2016) Effects of Intravenous Famotidine on Gastric Acid Secretion in Patients Undergoing Cardiac Surgery. Annals of Pharmacotherapy 29:4, pages 349-353.
Crossref
George D. Prell, Jack Peter Green, Charles A. Kaufmann, Jai K. Khandelwal, Albert M. Morrishow, Darrell G. Kirch, Markku Linnoila & Richard Jed Wyatt. (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophrenia Research 14:2, pages 93-104.
Crossref
Bertil K. J. Wagner, Louis T. Fazio, David W. Amory, Claudine M. Majcher, Alan J. Spotnitz & Gregory E. Scott. (2012) Famotidine Pharmacokinetics in Patients Undergoing Cardiac Surgery. Drug Investigation 8:5, pages 271-277.
Crossref
Kathleen D. Lake, Jacqueline G. Nolen, Ralph A. Slaker, Thomas J. Reutzel, Sherry K. Milfred, Diane F. Solbrack & Frances M. Hoffman. (2016) Over-the-Counter Medications in Cardiac Transplant Recipients: Guidelines for Use. Annals of Pharmacotherapy 26:12, pages 1566-1575.
Crossref
T. Liersch, J. -H. Beyer, G. Krieger & K. Vehmeyer. (1992) The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine. Annals of Hematology 64:5, pages 231-239.
Crossref
Kent D. Katz & Daniel Hollander. (1992) Practical pharmacology and cost-effective management of peptic ulcer disease. The American Journal of Surgery 163:3, pages 349-359.
Crossref
Charles D. Spaulding & Jeffry W. Joseph. (1992) Is Rx Couponing a Viable Direct-Marketing Technique?. American Pharmacy 32:1, pages 67-71.
Crossref
Thomas J. Humphries. (1991) Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole. Digestive Diseases and Sciences 36:12, pages 1665-1669.
Crossref
Kathleen D. Lake. (2012) Management of Drug Interactions With Cyclosporine. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 11:5.
Crossref
Thomas A. Miller, Michael S. Tornwall & Frank G. Moody. (1991) Stress erosive gastritis. Current Problems in Surgery 28:7, pages 459-509.
Crossref
Hisae Doi, Hideo Maruta, Ichidai Kudoh, Yoshiki Takahashi, Osami Takano, Kenichi Ogawa, Keiji Satoh & Yoshito Okutsu. (1991) Placental transfer and effects of famotidine on neonates. Journal of Anesthesia 5:3, pages 276-280.
Crossref
Stephen j. Sontag. (1990) The Medical Management of Reflux Esophagitis. Gastroenterology Clinics of North America 19:3, pages 683-712.
Crossref
Kamlesh P. Vyas, Prasad H. Kari, Regina W. Wang & Anthony Y.H. Lu. (1990) Biotransformation of lovastatin—III. Biochemical Pharmacology 39:1, pages 67-73.
Crossref
Paul F. Souney & Cheryl A. Stoukides. (2016) Pharmacoeconomic Aspects and Formulary Considerations Related to Histamine 2 -Receptor Antagonists . DICP 23:10_suppl, pages S29-S35.
Crossref
Vasilios A. Skoutakis. (2016) Comparison of the Parenteral Histamine 2 -Receptor Antagonists . DICP 23:10_suppl, pages S17-S22.
Crossref
C. GESPACH, D. FAGOT & S. EMAMI. (1989) Pharmacological control of the human gastric histamine H2 receptor by famotidine:comparison with H 1 , H 2 and H 3 receptor agonists and antagonists . European Journal of Clinical Investigation 19:s1, pages 1-10.
Crossref
K. M. COCHRAN, R. COCKEL, J. CROWE, R. J. DICKINSON, A. E. GENT, N. P. KENNEDY, C. M. S. ROYSTON, E. CEDAR & S. G. MANN. (2007) Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer. Alimentary Pharmacology & Therapeutics 3:5, pages 461-470.
Crossref
Dennis F. Thompson, Marsha A. Raebel, Elizabeth K. Hussey & George E. Dukes. (2016) Do All Histamine 2 -Antagonists Cause a Warfarin Drug Interaction? . DICP 23:9, pages 675-679.
Crossref
R. ALCALÁ SANTAELLA, J. GUARDIA, J. PAJARES, J. PIQUÉ, L. PITA, E. ALVÁREZ, P. CASTELLANOS, L. GUARNER, J. ORTIZ, R. PESQUERA, V. VARGAS & R. RUIZ‐CAPELLÁN. (2007) A multicentre, randomized, double‐blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration. Alimentary Pharmacology & Therapeutics 3:1, pages 103-110.
Crossref
M.I. Al-Hassan, S.A. Bawazir, K.M. Matar & A. Tekle. (1989) Effect of famotidine on theophylline pharmacokinetics in the rat. International Journal of Pharmaceutics 50:1, pages 35-38.
Crossref
C. GESPACH, D. FAGOt & S. EMAMI. (2008) Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H 1 , H 2 and H 3 receptor agonists and antagonists . European Journal of Clinical Investigation 19:1, pages 1-10.
Crossref
N. Inotsume, M. Nishimura, S. Fujiyama, K. Sagara, T. Sato, Y. Imai, H. Matsui & M. Nakano. (1989) Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers. European Journal of Clinical Pharmacology 36:5, pages 517-520.
Crossref
R. Giacomelli, V. Filingeri, G. Famularo, A. Calogero, F. Stortoni, S. Nardi, R. Rosati, A. Iacona, S. Sacchetti, V. Cervelli, R. Verna, G. Tonietti & C. U. Casciani. 1989. Current Therapy in Nephrology. Current Therapy in Nephrology 529 531 .
Jean-Pierre Aymard, Bernadette Aymard, Patrick Netter, Bernard Bannwarth, Philippe Trechot & François Streiff. (2012) Haematological Adverse Effects of Histamine H2-Receptor Antagonists. Medical Toxicology 3:6, pages 430-448.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.